BIOMAT Database Logo BIOMAT Database Logo

[Antibacterial activity of ristocetin]. 1958

A FARULLA, and A CASSANO, and L NUZZOLO, and G GIORDANO

UI MeSH Term Description Entries
D003879 Dermatologic Agents Drugs used to treat or prevent skin disorders or for the routine care of skin. Agent, Dermatologic,Agent, Dermatological,Agents, Dermatologic,Dermatologic Agent,Dermatological Agents,Agents, Dermatological,Dermatological Agent
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D000904 Antibiotics, Antitubercular Substances obtained from various species of microorganisms that are, alone or in combination with other agents, of use in treating various forms of tuberculosis; most of these agents are merely bacteriostatic, induce resistance in the organisms, and may be toxic. Antitubercular Antibiotics
D001419 Bacteria One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive. Eubacteria
D012310 Ristocetin An antibiotic mixture of two components, A and B, obtained from Nocardia lurida (or the same substance produced by any other means). It is no longer used clinically because of its toxicity. It causes platelet agglutination and blood coagulation and is used to assay those functions in vitro. Ristomycin

Related Publications

A FARULLA, and A CASSANO, and L NUZZOLO, and G GIORDANO
[Antibacterial activity of ristocetin in combination with various antibiotics].
March 1959, La Clinica terapeutica,
A FARULLA, and A CASSANO, and L NUZZOLO, and G GIORDANO
[Antibacterial activity in vitro of ristocetin, kanamycin and farmiglucine].
December 1964, Bollettino della Societa italiana di biologia sperimentale,
A FARULLA, and A CASSANO, and L NUZZOLO, and G GIORDANO
[Ristocetin: characteristics, antibacterial activity, absorption, elimination & concentration in various organic liquids].
April 1958, La Riforma medica,
A FARULLA, and A CASSANO, and L NUZZOLO, and G GIORDANO
[Antibacterial activity of ristocetin, kanamycin and farmiglucine in association with other antibiotics].
December 1964, Bollettino della Societa italiana di biologia sperimentale,
A FARULLA, and A CASSANO, and L NUZZOLO, and G GIORDANO
Click reaction synthesis of carbohydrate derivatives from ristocetin aglycon with antibacterial and antiviral activity.
May 2010, Bioorganic & medicinal chemistry letters,
A FARULLA, and A CASSANO, and L NUZZOLO, and G GIORDANO
Synthesis of fluorescent ristocetin aglycon derivatives with remarkable antibacterial and antiviral activities.
December 2012, European journal of medicinal chemistry,
A FARULLA, and A CASSANO, and L NUZZOLO, and G GIORDANO
Ristocetin-Willebrand factor activity in dog plasma.
September 1980, Canadian journal of physiology and pharmacology,
A FARULLA, and A CASSANO, and L NUZZOLO, and G GIORDANO
Ristocetin, the development of resistance and bactericidal activity.
January 1956, Antibiotics annual,
A FARULLA, and A CASSANO, and L NUZZOLO, and G GIORDANO
Destruction of the platelet aggregating activity of ristocetin A.
April 1978, Experientia,
A FARULLA, and A CASSANO, and L NUZZOLO, and G GIORDANO
Ristocetin.
November 1959, Canadian Medical Association journal,
Copied contents to your clipboard!